Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 16, 2024

SELL
$10.21 - $15.27 $1,368 - $2,046
-134 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$14.07 - $17.3 $1,885 - $2,318
134 New
134 $1.96 Million
Q1 2021

Aug 16, 2024

BUY
$15.15 - $19.78 $1,515 - $1,978
100 Added 294.12%
134 $2.32 Million
Q1 2020

Aug 16, 2024

SELL
$16.28 - $25.63 $26,959 - $42,443
-1,656 Reduced 97.99%
34 $685,000
Q4 2019

Aug 16, 2024

BUY
$19.57 - $23.52 $33,073 - $39,748
1,690 New
1,690 $39.4 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.44B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.